Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Mitsubishi files for European approval of argatroban, establishes German subsidiary

May 28, 2003

ThromboGenics completes phase I trial of microplasmin for thromboembolic diseases

May 27, 2003

Fondaparinux better than enoxaparin in preventing postsurgical venous thromboembolism

May 22, 2003

Thrombin receptor antagonists claimed by Schering-Plough

May 19, 2003

BM-573 prevents coronary artery thrombosis and myocardial infarction

May 15, 2003

New data on urokinase in intracerebral hematoma

April 22, 2003

Macrocyclic thrombin inhibitors with high potency and selectivity

April 15, 2003

New series of platelet ADP receptor inhibitors identified at Millennium

April 15, 2003

Synergistic effect found for pravastatin on the anticoagulant action of LMWH

April 14, 2003

Anticoagulant efficacy of JVT-803 demonstrated in porcine model of hemodialysis

April 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...